Jefferies initiates coverage on Bio-Reference Laboratories Inc (Nasdaq: BRLI) with a 'Buy' rating and $22 price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE